Atopic Eczema Treatment Market Size, Share & Growth Analysis Report 2026

Industry Insights

[195+ Pages Report] According to the report published by Facts & Factors, the global atopic eczema treatment market was estimated at approximately USD 18,057.4 Million in 2019 and is anticipated to generate revenue of around USD 34,089.3 Million by end of 2026, growing at a CAGR of around 10.36% between 2020 and 2026.

Market Overview

Eczema (atopic dermatitis) is a skin disease that causes itchiness on the skin and making the skin surface look dry and red. It's more common in kids, but it can strike someone at any age. Atopic dermatitis is a long-term (chronic) condition that flares up from time to time. There is yet no treatment for atopic eczema, but doctors suggest self-care treatments helping to ease itching and deter new outbreaks. Some treatments that are considered to be beneficial are avoiding any usage of harsh soaps, moisturizing the skin regularly, and applying medicated creams or ointments.

Industry Growth Factors

The atopic eczema treatment industry has gained momentum in recent years as people have become more knowledgeable of the disease's care options. Government initiatives to offer quality and more affordable care, as well as the presence of attractive payment plans, is expected to give the industry a boost. One of the big roadblocks in the market's upward climb is the high cost of therapeutics. Affordable healthcare policies, on the other hand, are being implemented in all main countries, affecting company price plans as well as payment possibilities. Nevertheless, there are multiple opportunities where a permanent cure for the disease could be developed by the key players or else can develop a systematic treatment to recover affected patients from atopic eczema infections.

Segmentation Analysis

Based on the type segment, the atopic eczema treatment market is divided into topical, oral, and injectable, out of which, the topical type holds the maximum market share as they are widely prescribed and used drugs in atopic eczema treatments. They are generally using in combination with moisturizers or emollients as they give more effective results in this way. These topical creams can be easily applied and washed from the skin. These topical moisturizers are anti-inflammatory helping to lower skin itching and rash, thus helping to lock in the water and avoid more dryness.

On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The segment of online pharmacies holds the largest share as compared with other segments as it gives access to eczema treatment medicines with various brands to choose from with varying prices. Online pharmacies are also helpful for those who have a busy lifestyle and do not have time to visit a local pharmacy or else for the people who live a long way from their nearest pharmacy.

The elderly people who are unable to travel independently also prefer ordering their medicines from online pharmacies. Online pharmacies also helped in delivering medicines to the patients who were under lockdown and were unable to get their medicines from the local pharmacy store. It also helped in delivering the medicines on time as COVID-19 had an impact on the delivery duration of medicines in the local pharmacies.

Report Scope

Regional Analysis

The region of North America is anticipated to dominate the atopic eczema treatment market over the forecasted period owing to well-developed technologies, an increase in patients with poor protein filaggrin levels, an increase in the incidence of atopic disease, high healthcare expenditures, and increased government funding for R&D. Furthermore, the demand in this area has grown owing to increased R&D activities and the presence of major companies in the region.

Owing to the surging government funding for research and development and the availability of funds for research, Europe ranks second in the global atopic eczema treatment industry. Over the forecasted timeframe, this is likely to continue to drive the European economy. Countries such as Germany and France, for example, are growing their investments in healthcare. Due to rapidly evolving healthcare technologies, a large patient population, and high healthcare spending, Asia Pacific is the fastest growing atopic eczema treatment market. Furthermore, developing demand for new treatment approaches in countries such as India and South Korea is projected to emerge as the world's fastest-growing market. Furthermore, the demand for high-quality medical products is expected to lead to an increased usage of advanced equipment, which will boost atopic eczema treatment market growth in the area.

Competitive Players

• Encore Dermatology Inc.
• AbbieVie Inc.
• F. Hoffmann-La Roche AG
• Novartis AG
• Glaxosmithklineplc
• Regeneron Pharmaceuticals Inc.
• Medimmune LLC. (Astrazeneca)
• LEO Pharma A/S
• Sanofi S.A
• Valeant Pharmaceuticals Inc.
• Pfizer Inc

This report segments the Atopic Eczema Treatment market as follows:

By Type Based Segmentation Analysis:

• Topical
• Oral
• Injectable

By Application Segmentation Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA